| Cancer statistics, 2007 | Ca-A Cancer Journal for Clinicians | 2007 | 6.4K |
| Revised response criteria for malignant lymphoma | Journal of Clinical Oncology | 2007 | 3.5K |
| The resurgence of platinum-based cancer chemotherapy | Nature Reviews Cancer | 2007 | 3.4K |
| HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis | Pediatric Blood and Cancer | 2007 | 3K |
| Triple-negative breast cancer: clinical features and patterns of recurrence | Clinical Cancer Research | 2007 | 3K |
| Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group | Journal of Clinical Oncology | 2007 | 2.9K |
| The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours | Journal of Thoracic Oncology | 2007 | 2.7K |
| Identification of pancreatic cancer stem cells | Cancer Research | 2007 | 2.7K |
| American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer | Journal of Clinical Oncology | 2007 | 2.6K |
| Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? | Nature Reviews Cancer | 2007 | 2.5K |
| Defining the role of mTOR in cancer | Cancer Cell | 2007 | 2.4K |
| Epidermal growth factor receptor mutations in lung cancer | Nature Reviews Cancer | 2007 | 2.3K |
| Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer | Oncogene | 2007 | 2.1K |
| MAP kinase signalling pathways in cancer | Oncogene | 2007 | 2K |
| Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis | Nature Reviews Cancer | 2007 | 1.9K |
| Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200 | Journal of Clinical Oncology | 2007 | 1.9K |
| American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography | Ca-A Cancer Journal for Clinicians | 2007 | 1.8K |
| Estimates of the cancer incidence and mortality in Europe in 2006 | Annals of Oncology | 2007 | 1.8K |
| American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer | Journal of Clinical Oncology | 2007 | 1.8K |
| A perivascular niche for brain tumor stem cells | Cancer Cell | 2007 | 1.7K |
| The Bcl-2 apoptotic switch in cancer development and therapy | Oncogene | 2007 | 1.6K |
| Hypoxia in cancer: significance and impact on clinical outcome | Cancer and Metastasis Reviews | 2007 | 1.6K |
| Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer | Journal of Clinical Oncology | 2007 | 1.6K |
| Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles | Neoplasia | 2007 | 1.5K |
| The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes | Clinical Cancer Research | 2007 | 1.5K |
